Immuno Cure 3 Limited
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV) (NCT05904054) | Immuno Cure 3 Limited | 2023-06-15 |
Track Immuno Cure 3 Limited automatically
Every clearance here is in the API, with alerts when new ones post.